SDGR Strangle Strategy
SDGR (Schrödinger, Inc.), in the Healthcare sector, (Medical - Healthcare Information Services industry), listed on NASDAQ.
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
SDGR (Schrödinger, Inc.) trades in the Healthcare sector, specifically Medical - Healthcare Information Services, with a market capitalization of approximately $952.7M, a beta of 1.58 versus the broader market, a 52-week range of 10.945-27.63, average daily share volume of 1.4M, a public-listing history dating back to 2020, approximately 891 full-time employees. These structural characteristics shape how SDGR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.58 indicates SDGR has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a strangle on SDGR?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current SDGR snapshot
As of May 15, 2026, spot at $11.95, ATM IV 77.20%, IV rank 57.13%, expected move 22.13%. The strangle on SDGR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on SDGR specifically: SDGR IV at 77.20% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 22.13% (roughly $2.64 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SDGR expiries trade a higher absolute premium for lower per-day decay. Position sizing on SDGR should anchor to the underlying notional of $11.95 per share and to the trader's directional view on SDGR stock.
SDGR strangle setup
The SDGR strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SDGR near $11.95, the first option leg uses a $12.55 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SDGR chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SDGR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $12.55 | N/A |
| Buy 1 | Put | $11.35 | N/A |
SDGR strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
SDGR strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on SDGR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on SDGR
Strangles on SDGR are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the SDGR chain.
SDGR thesis for this strangle
The market-implied 1-standard-deviation range for SDGR extends from approximately $9.31 on the downside to $14.59 on the upside. A SDGR long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current SDGR IV rank near 57.13% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on SDGR should anchor more to the directional view and the expected-move geometry. As a Healthcare name, SDGR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SDGR-specific events.
SDGR strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SDGR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SDGR alongside the broader basket even when SDGR-specific fundamentals are unchanged. Always rebuild the position from current SDGR chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on SDGR?
- A strangle on SDGR is the strangle strategy applied to SDGR (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With SDGR stock trading near $11.95, the strikes shown on this page are snapped to the nearest listed SDGR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are SDGR strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the SDGR strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 77.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a SDGR strangle?
- The breakeven for the SDGR strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SDGR market-implied 1-standard-deviation expected move is approximately 22.13%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on SDGR?
- Strangles on SDGR are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the SDGR chain.
- How does current SDGR implied volatility affect this strangle?
- SDGR ATM IV is at 77.20% with IV rank near 57.13%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.